Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Leishmaniasis Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Leishmaniasis Treatmentmarket, defines the market attractiveness level of Leishmaniasis Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Leishmaniasis Treatment industry, describes the types of Leishmaniasis Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Leishmaniasis Treatment market and the development prospects and opportunities of Leishmaniasis Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Leishmaniasis Treatment market in Chapter 13.
By Player:
Dafra Pharma
Merck
AEterna Zentaris AG
AEterna Zentaris
Pieris Pharmaceuticals
Eurofins Advinus
iCo Therapeutics
By Type:
Meglumine Antimoniate
Pentamidine
Hydroxyl Amidine Stilbene
Amphotericin B
By End-User:
Visceral Leishmaniasis
Cutaneous Leishmaniasis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Leishmaniasis Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Leishmaniasis Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Leishmaniasis Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Leishmaniasis Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Leishmaniasis Treatment Market Analysis and Outlook to 2022
-
7.1 Global Leishmaniasis Treatment Consumption (2017-2022)
-
7.2 United States Leishmaniasis Treatment Consumption (2017-2022)
-
7.3 Europe Leishmaniasis Treatment Consumption (2017-2022)
-
7.4 China Leishmaniasis Treatment Consumption (2017-2022)
-
7.5 Japan Leishmaniasis Treatment Consumption (2017-2022)
-
7.6 India Leishmaniasis Treatment Consumption (2017-2022)
-
7.7 South Korea Leishmaniasis Treatment Consumption (2017-2022)
8 Region and Country-wise Leishmaniasis Treatment Market Analysis and Outlook to 2028
-
8.1 Global Leishmaniasis Treatment Consumption Forecast (2022-2028)
-
8.2 United States Leishmaniasis Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Leishmaniasis Treatment Consumption Forecast (2022-2028)
-
8.4 China Leishmaniasis Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Leishmaniasis Treatment Consumption Forecast (2022-2028)
-
8.6 India Leishmaniasis Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Leishmaniasis Treatment Consumption Forecast (2022-2028)
9 Global Leishmaniasis Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Leishmaniasis Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Meglumine Antimoniate Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pentamidine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hydroxyl Amidine Stilbene Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Amphotericin B Consumption and Growth Rate (2017-2022)
-
9.2 Global Leishmaniasis Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Visceral Leishmaniasis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cutaneous Leishmaniasis Consumption and Growth Rate (2017-2022)
10 Global Leishmaniasis Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Leishmaniasis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Meglumine Antimoniate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pentamidine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Hydroxyl Amidine Stilbene Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Amphotericin B Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Leishmaniasis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Visceral Leishmaniasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cutaneous Leishmaniasis Consumption Forecast and Growth Rate (2022-2028)
11 Global Leishmaniasis Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Leishmaniasis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Leishmaniasis Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Leishmaniasis Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Leishmaniasis Treatment Market Competitive Analysis
-
14.1 Dafra Pharma
-
14.1.1 Dafra Pharma Company Details
-
14.1.2 Dafra Pharma Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Dafra Pharma Leishmaniasis Treatment Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Leishmaniasis Treatment Product and Service
-
14.3 AEterna Zentaris AG
-
14.3.1 AEterna Zentaris AG Company Details
-
14.3.2 AEterna Zentaris AG Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AEterna Zentaris AG Leishmaniasis Treatment Product and Service
-
14.4 AEterna Zentaris
-
14.4.1 AEterna Zentaris Company Details
-
14.4.2 AEterna Zentaris Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AEterna Zentaris Leishmaniasis Treatment Product and Service
-
14.5 Pieris Pharmaceuticals
-
14.5.1 Pieris Pharmaceuticals Company Details
-
14.5.2 Pieris Pharmaceuticals Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pieris Pharmaceuticals Leishmaniasis Treatment Product and Service
-
14.6 Eurofins Advinus
-
14.6.1 Eurofins Advinus Company Details
-
14.6.2 Eurofins Advinus Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eurofins Advinus Leishmaniasis Treatment Product and Service
-
14.7 iCo Therapeutics
-
14.7.1 iCo Therapeutics Company Details
-
14.7.2 iCo Therapeutics Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 iCo Therapeutics Leishmaniasis Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Leishmaniasis Treatment
-
Figure Leishmaniasis Treatment Picture
-
Table Global Leishmaniasis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Leishmaniasis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Leishmaniasis Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Leishmaniasis Treatment Consumption by Country (2017-2022)
-
Figure United States Leishmaniasis Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Leishmaniasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Leishmaniasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Leishmaniasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Leishmaniasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Leishmaniasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Leishmaniasis Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Leishmaniasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Leishmaniasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Leishmaniasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Leishmaniasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Leishmaniasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Leishmaniasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Meglumine Antimoniate Consumption and Growth Rate (2017-2022)
-
Figure Global Pentamidine Consumption and Growth Rate (2017-2022)
-
Figure Global Hydroxyl Amidine Stilbene Consumption and Growth Rate (2017-2022)
-
Figure Global Amphotericin B Consumption and Growth Rate (2017-2022)
-
Figure Global Visceral Leishmaniasis Consumption and Growth Rate (2017-2022)
-
Figure Global Cutaneous Leishmaniasis Consumption and Growth Rate (2017-2022)
-
Figure Global Meglumine Antimoniate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pentamidine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hydroxyl Amidine Stilbene Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amphotericin B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Visceral Leishmaniasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cutaneous Leishmaniasis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Leishmaniasis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Leishmaniasis Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Dafra Pharma (Foundation Year, Company Profile and etc.)
-
Table Dafra Pharma Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dafra Pharma Leishmaniasis Treatment Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Leishmaniasis Treatment Product and Service
-
Table AEterna Zentaris AG (Foundation Year, Company Profile and etc.)
-
Table AEterna Zentaris AG Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AEterna Zentaris AG Leishmaniasis Treatment Product and Service
-
Table AEterna Zentaris (Foundation Year, Company Profile and etc.)
-
Table AEterna Zentaris Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AEterna Zentaris Leishmaniasis Treatment Product and Service
-
Table Pieris Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Pieris Pharmaceuticals Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pieris Pharmaceuticals Leishmaniasis Treatment Product and Service
-
Table Eurofins Advinus (Foundation Year, Company Profile and etc.)
-
Table Eurofins Advinus Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eurofins Advinus Leishmaniasis Treatment Product and Service
-
Table iCo Therapeutics (Foundation Year, Company Profile and etc.)
-
Table iCo Therapeutics Leishmaniasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table iCo Therapeutics Leishmaniasis Treatment Product and Service
-
